TY  - JOUR
A1  - Mitchell, Jonathan S.
A1  - Li, Ni
A1  - Weinhold, Niels
A1  - Försti, Asta
A1  - Ali, Mina
A1  - van Duin, Mark
A1  - Thorleifsson, Gudmar
A1  - Johnson, David C.
A1  - Chen, Bowang
A1  - Halvarsson, Britt-Marie
A1  - Gudbjartsson, Daniel F.
A1  - Kuiper, Rowan
A1  - Stephens, Owen W.
A1  - Bertsch, Uta
A1  - Broderick, Peter
A1  - Campo, Chiara
A1  - Einsele, Hermann
A1  - Gregory, Walter A.
A1  - Gullberg, Urban
A1  - Henrion, Marc
A1  - Hillengass, Jens
A1  - Hoffmann, Per
A1  - Jackson, Graham H.
A1  - Johnsson, Ellinor
A1  - Jöud, Magnus
A1  - Kristinsson, Sigurdur Y.
A1  - Lenhoff, Stig
A1  - Lenive, Oleg
A1  - Mellqvist, Ulf-Henrik
A1  - Migliorini, Gabriele
A1  - Nahi, Hareth
A1  - Nelander, Sven
A1  - Nickel, Jolanta
A1  - Nöthen, Markus M.
A1  - Rafnar, Thorunn
A1  - Ross, Fiona M.
A1  - da Silva Filho, Miguel Inacio
A1  - Swaminathan, Bhairavi
A1  - Thomsen, Hauke
A1  - Turesson, Ingemar
A1  - Vangsted, Annette
A1  - Vogel, Ulla
A1  - Waage, Anders
A1  - Walker, Brian A.
A1  - Wihlborg, Anna-Karin
A1  - Broyl, Annemiek
A1  - Davies, Faith E.
A1  - Thorsteinsdottir, Unnur
A1  - Langer, Christian
A1  - Hansson, Markus
A1  - Kaiser, Martin
A1  - Sonneveld, Pieter
A1  - Stefansson, Kari
A1  - Morgan, Gareth J.
A1  - Goldschmidt, Hartmut
A1  - Hemminki, Kari
A1  - Nilsson, Björn
A1  - Houlston, Richard S.
T1  - Genome-wide association study identifies multiple susceptibility loci for multiple myeloma
JF  - Nature Communications
N2  - Multiple myeloma (MM) is a plasma cell malignancy with a significant heritable basis. Genome-wide association studies have transformed our understanding of MM predisposition, but individual studies have had limited power to discover risk loci. Here we perform a meta-analysis of these GWAS, add a new GWAS and perform replication analyses resulting in 9,866 cases and 239,188 controls. We confirm all nine known risk loci and discover eight new loci at 6p22.3 (rs34229995, P=1.31 × 10−8), 6q21 (rs9372120, P=9.09 × 10−15), 7q36.1 (rs7781265, P=9.71 × 10−9), 8q24.21 (rs1948915, P=4.20 × 10−11), 9p21.3 (rs2811710, P=1.72 × 10−13), 10p12.1 (rs2790457, P=1.77 × 10−8), 16q23.1 (rs7193541, P=5.00 × 10−12) and 20q13.13 (rs6066835, P=1.36 × 10−13), which localize in or near to JARID2, ATG5, SMARCD3, CCAT1, CDKN2A, WAC, RFWD3 and PREX1. These findings provide additional support for a polygenic model of MM and insight into the biological basis of tumour development.
KW  - Cancer genetics
KW  - Genome-wide association studies
KW  - Myeloma
Y1  - 2016
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-165983
VL  - 7
ER  - 
TY  - JOUR
A1  - Isles, Anthony R.
A1  - Ingason, Andrés
A1  - Lowther, Chelsea
A1  - Walters, James
A1  - Gawlick, Micha
A1  - Stöber, Gerald
A1  - Rees, Elliott
A1  - Martin, Joanna
A1  - Little, Rosie B.
A1  - Potter, Harry
A1  - Georgieva, Lyudmila
A1  - Pizzo, Lucilla
A1  - Ozaki, Norio
A1  - Aleksic, Branko
A1  - Kushima, Itaru
A1  - Ikeda, Masashi
A1  - Iwata, Nakao
A1  - Levinson, Douglas F.
A1  - Gejman, Pablo V.
A1  - Shi, Jianxin
A1  - Sanders, Alan R.
A1  - Duan, Jubao
A1  - Willis, Joseph
A1  - Sisodiya, Sanjay
A1  - Costain, Gregory
A1  - Werge, Thomas M.
A1  - Degenhardt, Franziska
A1  - Giegling, Ina
A1  - Rujescu, Dan
A1  - Hreidarsson, Stefan J.
A1  - Saemundsen, Evald
A1  - Ahn, Joo Wook
A1  - Ogilvie, Caroline
A1  - Girirajan, Santhosh D.
A1  - Stefansson, Hreinn
A1  - Stefansson, Kari
A1  - O'Donovan, Michael C.
A1  - Owen, Michael J.
A1  - Bassett, Anne
A1  - Kirov, George
T1  - Parental Origin of Interstitial Duplications at 15q11.2-q13.3 in Schizophrenia and Neurodevelopmental Disorders
JF  - PLoS Genetics
N2  - Duplications at 15q11.2-q13.3 overlapping the Prader-Willi/Angelman syndrome (PWS/AS) region have been associated with developmental delay (DD), autism spectrum disorder (ASD) and schizophrenia (SZ). Due to presence of imprinted genes within the region, the parental origin of these duplications may be key to the pathogenicity. Duplications of maternal origin are associated with disease, whereas the pathogenicity of paternal ones is unclear. To clarify the role of maternal and paternal duplications, we conducted the largest and most detailed study to date of parental origin of 15q11.2-q13.3 interstitial duplications in DD, ASD and SZ cohorts. We show, for the first time, that paternal duplications lead to an increased risk of developing DD/ASD/multiple congenital anomalies (MCA), but do not appear to increase risk for SZ. The importance of the epigenetic status of 15q11.2-q13.3 duplications was further underlined by analysis of a number of families, in which the duplication was paternally derived in the mother, who was unaffected, whereas her offspring, who inherited a maternally derived duplication, suffered from psychotic illness. Interestingly, the most consistent clinical characteristics of SZ patients with 15q11.2-q13.3 duplications were learning or developmental problems, found in 76% of carriers. Despite their lower pathogenicity, paternal duplications are less frequent in the general population with a general population prevalence of 0.0033% compared to 0.0069% for maternal duplications. This may be due to lower fecundity of male carriers and differential survival of embryos, something echoed in the findings that both types of duplications are de novo in just over 50% of cases. Isodicentric chromosome 15 (idic15) or interstitial triplications were not observed in SZ patients or in controls. Overall, this study refines the distinct roles of maternal and paternal interstitial duplications at 15q11.2-q13.3, underlining the critical importance of maternally expressed imprinted genes in the contribution of Copy Number Variants (CNVs) at this interval to the incidence of psychotic illness. This work will have tangible benefits for patients with 15q11.2-q13.3 duplications by aiding genetic counseling.
KW  - interstitial duplications
KW  - schizophrenia
KW  - developmental delay
KW  - autism spectrum disorder
KW  - parental origin
KW  - genetics
Y1  - 2016
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-166706
VL  - 12
IS  - 5
ER  - 
TY  - JOUR
A1  - Kiryluk, Krzysztof
A1  - Yifu, Li
A1  - Sanna-Cherchi, Simone
A1  - Rohanizadegan, Mersedeh
A1  - Suzuki, Hitoshi
A1  - Eitner, Frank
A1  - Snyder, Holly J.
A1  - Choi, Murim
A1  - Hou, Ping
A1  - Scolari, Francesco
A1  - Izzi, Claudia
A1  - Gigante, Maddalena
A1  - Gesualdo, Loreto
A1  - Savoldi, Silvana
A1  - Amoroso, Antonio
A1  - Cusi, Daniele
A1  - Zamboli, Pasquale
A1  - Julian, Bruce A.
A1  - Novak, Jan
A1  - Wyatt, Robert J.
A1  - Mucha, Krzysztof
A1  - Perola, Markus
A1  - Kristiansson, Kati
A1  - Viktorin, Alexander
A1  - Magnusson, Patrik K.
A1  - Thorleifsson, Gudmar
A1  - Thorsteinsdottir, Unnur
A1  - Stefansson, Kari
A1  - Boland, Anne
A1  - Metzger, Marie
A1  - Thibaudin, Lise
A1  - Wanner, Christoph
A1  - Jager, Kitty J.
A1  - Goto, Shin
A1  - Maixnerova, Dita
A1  - Karnib, Hussein H.
A1  - Nagy, Judit
A1  - Panzer, Ulf
A1  - Xie, Jingyuan
A1  - Chen, Nan
A1  - Tesar, Vladimir
A1  - Narita, Ichiei
A1  - Berthoux, Francois
A1  - Floege, Jürgen
A1  - Stengel, Benedicte
A1  - Zhang, Hong
A1  - Lifton, Richard P.
A1  - Gharavi, Ali G.
T1  - Geographic Differences in Genetic Susceptibility to IgA Nephropathy: GWAS Replication Study and Geospatial Risk Analysis
JF  - PLoS Genetics
N2  - IgA nephropathy (IgAN), major cause of kidney failure worldwide, is common in Asians, moderately prevalent in Europeans, and rare in Africans. It is not known if these differences represent variation in genes, environment, or ascertainment. In a recent GWAS, we localized five IgAN susceptibility loci on Chr.6p21 (HLA-DQB1/DRB1, PSMB9/TAP1, and DPA1/DPB2 loci), Chr.1q32 (CFHR3/R1 locus), and Chr.22q12 (HORMAD2 locus). These IgAN loci are associated with risk of other immune-mediated disorders such as type I diabetes, multiple sclerosis, or inflammatory bowel disease. We tested association of these loci in eight new independent cohorts of Asian, European, and African-American ancestry (N = 4,789), followed by meta-analysis with risk-score modeling in 12 cohorts (N = 10,755) and geospatial analysis in 85 world populations. Four susceptibility loci robustly replicated and all five loci were genome-wide significant in the combined cohort (P = 5x10\(^{-32}\) 3x10\(^{-10}\), with heterogeneity detected only at the PSMB9/TAP1 locus (I\(^{-2}\) = 0.60). Conditional analyses identified two new independent risk alleles within the HLA-DQB1/DRB1 locus, defining multiple risk and protective haplotypes within this interval. We also detected a significant genetic interaction, whereby the odds ratio for the HORMAD2 protective allele was reversed in homozygotes for a CFHR3/R1 deletion (P = 2.5x10\(^{-4}\)). A seven-SNP genetic risk score, which explained 4.7% of overall IgAN risk, increased sharply with Eastward and Northward distance from Africa (r = 0.30, P = 3x10\(^{-128}\)). This model paralleled the known East-West gradient in disease risk. Moreover, the prediction of a South-North axis was confirmed by registry data showing that the prevalence of IgAN-attributable kidney failure is increased in Northern Europe, similar to multiple sclerosis and type I diabetes. Variation at IgAN susceptibility loci correlates with differences in disease prevalence among world populations. These findings inform genetic, biological, and epidemiological investigations of IgAN and permit cross-comparison with other complex traits that share genetic risk loci and geographic patterns with IgAN.
KW  - linkage
KW  - genome-wide association
KW  - multiple sclerosis
KW  - renal disease
KW  - New mexico
KW  - recombination hotspot
KW  - italian population
KW  - natural history
KW  - HLA
KW  - glomerulonephritis
Y1  - 2012
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-130195
VL  - 8
IS  - 6
ER  -